Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Biopharmaceuticals market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

306 Item(s)

Page 1 of 31

  1. Global mAb Biosimilars Market 2016-2020

    By: Technavio
    , Published: Sep-2016
    , Product code: IRTNTR10349
    The report covers the present scenario and the growth prospects of the global monoclonal antibody (mAb) biosimilars market 2016-2020. To calculate the market size, the report considers the report considers the revenue generated from the sales of mAbs. The report also considers the revenues generated from the sales of drugs that are expected to be launched during the forecast period.
    $2,500.00

  2. Global Biosimilars Market 2016-2020

    By: Technavio
    , Published: Aug-2016
    , Product code: IRTNTR10077
    The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
    $2,500.00

  3. Global Licensing Partnering - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2063
    The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies
    $2,995.00

  4. Global Joint Venture Partnerships 2010-2016 - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2060
    The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies
    $1,995.00

  5. Global Discovery Stage Partnering - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2056
    The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies
    $2,995.00

  6. Global Preclinical Stage Partnering - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2057
    The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

  7. Global Clinical Stage Partnering - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2058
    The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the worlds leading biopharma companies
    $2,995.00

  8. Global Option and Evaluation Partnerships 2010-2016 - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2059
    The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies
    $2,995.00

  9. Global Biosimulation Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Apr-2016
    , Product code: HAD-1261015
    Biosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of biological systems e.g. the response of an organ or a single cell towards a chemical. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials.
    $3,900.00

  10. Global Molecular Diagnostics Partnering 2010-2016 - Apr2016.pdf

    By: Current Partnering
    , Published: Apr-2016
    , Product code: CP2102mol
    Global Molecular Diagnostics Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

306 Item(s)

Page 1 of 31